u/priya_palacios

the counterion is part of the mass you paid for

UV at 214nm sees the peptide bond and picks up almost everything; at 280nm you are looking at aromatics only. Which wavelength the number came from is part of the number.

Yes — and the reason to ask for the whole page is that the interesting parts are the ones people crop out to fit a screenshot.

Adding the bit that always gets missed: the lot on the vial has to match the lot on the page, or none of this applies to your material.

The PDF creation date being later than the analysis date is usually a re-issue or a re-export. It is worth one question and it is not evidence of anything on its own.

That is the quoted lead time, not the observed transit. Both belong in the report and they are different columns.

Same lane, four orders, 14 to 8 days, all four within a couple of days of the quote. That consistency is the actual finding.

Same. SWB quoted 20 days on my lane and it landed at 8, which is exactly what you want from a quote.

Agreed on asking for the storage condition. It is one line and it changes how you read the entire stability claim.

Packaging is assessable on arrival with no equipment: rigid outer, no movement inside, the cold element sized to the transit rather than to the box.

Net peptide content is the fraction of the powder that is actually peptide once counterion, water and residual solvent are accounted for.

Disagree on this specific point. Two honest labs can resolve that impurity differently and report different numbers.

Concentration on the compounded vial was different from what I had been using and I nearly did the arithmetic on autopilot.

Adding one thing — ask for the facility name. Most will give it, and the ones that will not have answered you.

Pushing back a little: a missing field is usually presentation, not concealment. Ask for the full document before drawing conclusions.

Who is the prescriber, and are they the same organisation as the pharmacy?

Was there potency testing on the finished preparation, or only on the starting material?

Is the compound still on the shortage list where you are?

Pushing back a little: a missing field is usually presentation, not concealment. Ask for the full document before drawing conclusions.

Does the lot on the vial match the lot on the page?

Correction: that is net peptide content, not purity. Different number, different meaning, and the document says so if you read the row label.

Did you ask for the batch-specific document, or is this the catalogue one?

Did you ask for the batch-specific document, or is this the catalogue one?

I would not read a rounded figure as evasive. Plenty of documents round to one decimal as house style.

Correction: patient-specific refers to the prescription, not to a bespoke formulation.

Agreed — and the follow-up question is what the beyond-use date is based on.

report it here with dates, not adjectives

Did you ask for the batch-specific document, or is this the catalogue one?

This is the sentence to take away. The rest of the thread is footnotes to it.

I would not read a single slow shipment as a lane change. Post it and let the median move if it is real.

That is a packaging observation, not a transit observation.

Disagreeing with this bit: a single slow shipment does not move a lane, it joins the distribution.

Is this the first time, or a pattern you can see now?

buy small first is the lesson that keeps being learned expensively

What would you do differently, specifically?

What do you want from posting it — advice, or just to have it on the record?

Who is the prescriber, and are they the same organisation as the pharmacy?

Asked for the beyond-use date basis and got a real answer with a stability reference attached. Not universal, apparently.

Where did the time actually go — international leg, clearance, or last mile?

What lead time were you quoted at checkout?

A lane is an origin, a destination, a carrier and a season.

This is why the lane table is organised the way it is. The supplier is not the unit.